OncoTherapy Science, Inc. (TYO:4564)
Japan · Delayed Price · Currency is JPY 20.00
-1.00 (-4.76%)
Jun 3, 2026, 3:30 PM JST
OncoTherapy Science Market Cap
OncoTherapy Science has a market cap or net worth of 8.06 billion as of June 2, 2026. Its market cap has increased by 27.08% in one year.
Market Cap
8.06B
Enterprise Value
5.97B
Revenue
808.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.00
Market Cap Chart
Since June 29, 2007, OncoTherapy Science's market cap has decreased from 13.84B to 8.06B, a decrease of -41.80%. That is a compound annual growth rate of -2.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 8.06B | 17.22% |
| Dec 30, 2025 | 6.87B | 1.20% |
| Dec 30, 2024 | 6.79B | 35.66% |
| Dec 29, 2023 | 5.01B | -50.03% |
| Dec 30, 2022 | 10.02B | -27.78% |
| Dec 30, 2021 | 13.87B | -31.60% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immuno-Biological Laboratories | 9.46B |
| Nano Holdings | 9.27B |
| CellSeed | 9.23B |
| Carna Biosciences | 8.65B |
| K Pharma,Inc. | 7.99B |
| MEDINET | 7.77B |
| Kidswell Bio | 7.39B |
| BrightPath Biotherapeutics | 7.30B |